Urinary excretion and external radiation dose from patients administered thallium-201 and technetium-99m methoxy isobutyl isonitrile

Radiation Protection Dosimetry

Volumn 95, Issue 1, 2001, Pages 59-61

  Sattari, A ^a   Dadashzadeh, S ^b   Nasiroghli, G ^b  

^a Nuclear Research Center for Agriculture and Medicine NRCAM   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137; COBALT 57; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; THALLIUM CHLORIDE TL 201;

ADULT; AGED; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DOSIMETRY; DRUG ACTIVITY; DRUG CLEARANCE; DRUG URINE LEVEL; FEMALE; HUMAN; IONIZATION CHAMBER; MAJOR CLINICAL STUDY; MALE; NOTE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION MEASUREMENT; URINALYSIS; URINARY EXCRETION;

EID: 0034916295     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a006525     Document Type: Note

References (9)

1. Radioactive Contamination in Hospitals from Nuclear Medicine Patients
2. Cyclotrons and their Applications. The NRCAM Cyclotron Facilities
3. Addendum 1 to Publication 53. Radiation Dose to Patients from Radiopharmaceuticals
4. Radiation Dose Rates from Adult Patients undergoing Nuclear Medicine Investigation
5. Urinary Excretion and External Radiation Dose from Patients Administrated with Radiopharmaceuticals
6. The Radiation Dose to Accompanying Nurses, Relatives and other Patients in Nuclear Medicine Department Waiting Room
7. Dose Rates from Patients having Nuclear Medicine Investigation
8. Radioactive Patients